Clinical Trials Logo

Hypercapnia clinical trials

View clinical trials related to Hypercapnia.

Filter by:

NCT ID: NCT02917668 Completed - Obesity Clinical Trials

Evaluation of the Risk of Hyperoxia-induced Hypercapnia in Obese Cardiac Surgery Patients

Start date: September 2016
Phase: N/A
Study type: Interventional

This study aims to evaluate the risk of hyperoxia-induced hypercapnia in post-op obese cardiac surgery patients. It will compare two oxygenation modes in terms of their effect on the arterial partial pressure of carbon dioxide (PaCO2) : manual titration of oxygen delivery for a peripheral oxygen saturation (SpO2) target of > or = 95 % versus automatic titration by a closed-loop system for a SpO2 target of 90%. 15 post-op obese cardiac surgery patients will be recruited and each will receive both interventions (cross-over design). The main outcome will be the PaCO2, which will be compared after each study period. The research hypothesis is that the usual SpO2 target of > or = 95 % is associated with a greater PaCO2 compared with a lesser SpO2 target of 90%.

NCT ID: NCT02914093 Terminated - COPD Clinical Trials

IMT in Hypercapnic Patients With COPD

THYPISK-f
Start date: September 2016
Phase: N/A
Study type: Interventional

The overall objective of the study is to investigate the feasibility of home based inspiratory muscle training (IMT) on chronic hypercapnia in patients with severe COPD, and to examine the relationship between inspiratory muscle strength and carbon dioxide level.

NCT ID: NCT02877290 Completed - COPD Clinical Trials

The Effect of Non-invasive Ventilation on the Oxygenation of Peripheral Muscle in Hypercapnic COPD Patients

Start date: August 2016
Phase: N/A
Study type: Interventional

In this study, 20 hypercapnic COPD patients will perform two constant workrate endurance cycle tests. One test will be while using non-invasive Ventilation (NIV) support, one without in a randomized cross-over design. The aim is to measure, whether NIV is able to change peripheral and respiratory muscle oxygenation.

NCT ID: NCT02874339 Recruiting - Clinical trials for Hypercapnic Respiratory Failure

High Flow Nasal Oxygen Versus VNI in Acute Hypercapnic Cardiogenic Pulmonary Edema

OPTICAP
Start date: October 26, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether high flow nasal oxygen (HFNO) therapy is non inferior to non invasive ventilation (NIV) in the immediate treatment of patients with acute hypercapnic cardiogenic pulmonary edema associated with respiratory failure in the emergency department.

NCT ID: NCT02840851 Completed - Healthy Clinical Trials

Brain Blood Flow: Age and Gender

Start date: November 2016
Phase:
Study type: Observational

Baseline cerebral blood flow through the middle cerebral artery (MCA) and cerebral vasodilator response of the MCA to inhaled carbon dioxide (CO2) will be measured in young women, young men, older women, and older men using Magnetic Resonance (MR) imaging and transcranial Doppler ultrasound (TCD). Data collection techniques will be compared.

NCT ID: NCT02801162 Terminated - Hypoxia Clinical Trials

Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard

Start date: September 2016
Phase: N/A
Study type: Interventional

Evaluate the precision and accuracy of the Proxima 3® System by obtaining quantitative clinical data at various time points. Compare the methods associated with obtaining blood gas results using the Proxima 3® System device versus a conventional ABG analyse. The aim of the investigator is to evaluate the precision and accuracy of the Proxima 3® ABG system parameters (pH, pCO2 pO2, hematocrit and potassium) in clinical practices with rapid changing context.

NCT ID: NCT02799875 Completed - Premature Neonate Clinical Trials

Late Permissive Hypercapnia for Intubated and Ventilated Preterm Infants

HYFIVE
Start date: December 2015
Phase: N/A
Study type: Interventional

Preterm infants, less than 37 weeks gestation with respiratory distress syndrome, who remain ventilated between 7 and 14 days after birth will be randomized to a ventilator strategy of either a higher level of permissive hypercapnia or of a lower level of permissive hypercapnia to determine if either strategy will increase the number of alive ventilator-free days in the 28 days after randomization.

NCT ID: NCT02757573 Completed - Hypercapnia Clinical Trials

The Right Ventricular Responses to Mild Hypercarbia After Mitral Valve Repair Surgery

Start date: April 2016
Phase: N/A
Study type: Interventional

The aims of the study is to investigate the right ventricular responses to mild hypercarbia after mitral valve prolapse repair surgery by the measurements obtained on pulmonary arterial catheter and transesophageal echocardiography.

NCT ID: NCT02699112 Completed - Clinical trials for Hypercapnic Respiratory Failure

Cardiac and Respiratory Function With Non-invasive Ventilation

CARE-NIV
Start date: November 2015
Phase:
Study type: Observational

To assess patients with hypercapnic respiratory failure using echocardiography,cardiac output measurements and markers of neural respiratory drive (EMGpara) prior to, during and after non-invasive ventilation (NIV) initiation, and to follow the patients for 3 months. The investigators hypothesize that the improvement in cardiac function and/or respiratory mechanics over time are associated with ongoing improvements in oxygenation, quality of life and exercise capacity.

NCT ID: NCT02680639 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease

The Use of High Frequency Oscillations With NIV in Hypercapnic COPD Participants

Start date: November 13, 2015
Phase: N/A
Study type: Interventional

Chronic Obstructive Pulmonary Disease (COPD) is a major cause of chronic morbidity and mortality throughout the world, being the fourth leading cause of death in the world. This study is designed to detect COPD participants with Expiratory Flow Limitation. EFL occurs when the airways become compressed which usually results when a pressure outside the airway exceeds the pressure inside the airway. Participants will undergo study eligibility procedures at visit 1. At visit 2 participants will undergo a baseline auto-EPAP (Expiratory Positive Airway Pressure) measurement. Then the order will be randomized to three different treatment methods. Between each treatment there will be at least a 10 minute washout period in order for CO2 to stabilize and return to baseline.